
Vaishali Pharma Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Vaishali Pharma s Q3 FY24 marked by a remarkable 37.59% increase in revenue".
Filed with NSE ·

Vaishali Pharma Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Vaishali Pharma s Q3 FY24 marked by a remarkable 37.59% increase in revenue".
6ix hasn’t read this filing yet.
Follow Vaishali Pharma into a list and get an email when it puts out news.
Follow Vaishali Pharma